Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
GMS Ophthalmol Cases ; 13: Doc01, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36875628

RESUMO

Astrocytic hamartoma is a benign glial tumor. It may be associated with tuberous sclerosis and can also be found incidentally on retinal examination as an isolated presentation. Here, we describe multimodal imaging characteristics of astrocytic hamartoma in a patient with retinitis pigmentosa. Spectral domain optical coherence tomography of both eyes showed moth-eaten optically empty spaces and hyperreflective dots along with foveal thinning. Multicolor image highlighted mulberry appearance of the lesion with green shift signifying elevated lesion. In infrared reflectance, lesion was hyporeflective with its margins well delineated. Green reflectance and blue reflectance highlighted calcification as multiple hyperreflective dots. Autofluorescence showed typical hyperautofluorescence.

2.
GMS Ophthalmol Cases ; 12: Doc07, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35291583

RESUMO

Choroidal osteoma is a rare benign tumor which is found in the posterior pole of the eye. We herein describe multimodal imaging in two cases of choroidal osteoma. Fundus of our first case showed a yellowish-orange colored subretinal lesion at the posterior pole. Multicolor imaging highlighted the lesion with greenish hue. Infrared reflectance showed hyporeflectance. A dense echogenic plaque persisting in lower gain was noted on B-scan. FFA showed hyperfluorescence with corresponding hypocyanescence on ICG. EDI OCT showed an increase in choroidal thickness with elevated retinal pigment epithelium. The second case showed choroidal osteoma with active choroidal neovascular membrane that responded to intravitreal injection of Ranibizumab.

5.
Semin Ophthalmol ; 32(6): 781-786, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27533737

RESUMO

PURPOSE: To report the visual outcome in choroidal neovascular membrane developing (CNVM) in eyes with central serous chorioretinopathy (CSCR) with our without prior focal laser. METHODS: A retrospective case series of eyes with CNVM secondary to CSCR treated with intravitreal anti-VEGF. RESULTS: Ten eyes of nine patients of CNVM with CSCR who underwent intravitreal anti-VEGF injections were analyzed. Five eyes had CNVM without prior laser photocoagulation, and five eyes developed CNVM after laser photocoagulation for CSCR. Intravitreal injection bevacizumab was given in five eyes and ranibizumab in five eyes. The lasered group had significantly shorter duration of the disease, fewer injections given, and better visual acuity at final follow-up (P <0.05). None had any recurrences of either CSCR or CNVM until the last follow-up. CONCLUSION: CNVM in CSCR with prior history of focal laser had better outcome than that developed de novo, without prior history of laser.


Assuntos
Inibidores da Angiogênese/uso terapêutico , Bevacizumab/uso terapêutico , Coriorretinopatia Serosa Central/complicações , Neovascularização de Coroide/tratamento farmacológico , Ranibizumab/uso terapêutico , Acuidade Visual/fisiologia , Adolescente , Adulto , Coriorretinopatia Serosa Central/tratamento farmacológico , Coriorretinopatia Serosa Central/cirurgia , Neovascularização de Coroide/fisiopatologia , Feminino , Angiofluoresceinografia , Humanos , Injeções Intravítreas , Fotocoagulação a Laser , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Tomografia de Coerência Óptica , Adulto Jovem
6.
Saudi J Ophthalmol ; 30(3): 207-209, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-28210186

RESUMO

Retinitis Pigmentosa (RP) has been reported to be associated with retinal hemangioma, retinal angiomatous proliferation, polypoidal choroidal vasculopathy and vasoproliferative tumours. However there is no previous report of choroidal nevus in an eye with RP. We describe such a case in which the eye with RP had a choroidal nevus at the macula. The coexistence of these two entities in the same eye emphasizes the need of careful examination of patients with RP. The presence of choroidal nevus warrants additional investigations such as B scan ultrasonography and a close follow-up to pick up changes in the nevus size and morphology.

7.
Asia Pac J Ophthalmol (Phila) ; 4(5): 286-92, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26181589

RESUMO

PURPOSE: The aim of this study was to review the clinical profile including predisposing systemic conditions, microorganisms responsible, clinical presentation, and outcomes of endogenous endophthalmitis (EE) in South India. DESIGN: This study is a retrospective, noncomparative case series. METHODS: This study presents a retrospective analysis of records of patients with EE in a 10-year period. RESULTS: A total of 61 eyes of 58 patients were included in the study. Preceding systemic illness or surgery was noted in 31 patients (53.4%). No predisposing condition was found in 27 patients (46.5%). All eyes had severe diffuse EE. Culture positivity was seen in 34 of 58 patients (58.6%). Gram-positive organisms were isolated in 9 cases (15.5%), and Gram-negative organisms were isolated in 20 cases (34.5%). Pseudomonas aeruginosa (13.8%) was the most common isolate. Eleven eyes (18%) were managed medically with intravenous and intravitreal antibiotics, and 38 eyes (62.3%) also underwent vitrectomy. Eight eyes (13.1%) required repeat vitrectomy, and 12 eyes (19.7%) were eviscerated. The mean follow-up was 16.2 ± 13.9 months. Final visual acuity of 20/200 or better was seen in 29.5% eyes. A favorable outcome was noted in culture-positive patients (P = 0.03) and in patients with no predisposing causes. CONCLUSIONS: This study provides information about the clinical and microbiologic profile of EE. Aggressive medical and surgical treatment can result in favorable outcomes.


Assuntos
Bacteriemia/microbiologia , Endoftalmite/microbiologia , Infecções Oculares Bacterianas/microbiologia , Adolescente , Adulto , Idoso , Antibacterianos/uso terapêutico , Humor Aquoso/microbiologia , Bacteriemia/diagnóstico , Bacteriemia/terapia , Bactérias/isolamento & purificação , Terapia Combinada , Endoftalmite/diagnóstico , Endoftalmite/terapia , Evisceração do Olho , Infecções Oculares Bacterianas/diagnóstico , Infecções Oculares Bacterianas/terapia , Feminino , Humanos , Índia , Injeções Intravenosas , Injeções Intravítreas , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Estudos Retrospectivos , Fatores de Risco , Centros de Atenção Terciária , Acuidade Visual/fisiologia , Vitrectomia , Corpo Vítreo/microbiologia
9.
Ocul Immunol Inflamm ; 22(3): 170-4, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24738972

RESUMO

PURPOSE: To determine the viral diagnosis and clinical outcome of eyes with acute retinal necrosis (ARN). METHOD: A retrospective analysis was done of 62 eyes of 53 patients presenting to a tertiary care ophthalmic institute between 1997 and 2007 with features of ARN. All patients with active disease were started immediately on intravenous acyclovir followed by oral antivirals along with systemic steroids. A prophylactic laser retinopexy was performed in patients with a clear media to areas posterior to the necrotic retina. RESULTS: The aqueous and the vitreous sample revealed herpes simplex virus in 19 (30.60%) and varicella zoster virus in 28 patients (45.16%). Forty-one (66.12%) eyes had retinal detachment. Prophylactic laser photocoagulation was given in 19 (30.64%) eyes. Surgical intervention was required in 32 (51.61%) eyes. Favorable functional outcome was seen in 28 (45.1%) eyes. CONCLUSION: ARN is a fulminant disorder, which if treated early and aggressively gives good results.


Assuntos
DNA Viral/análise , Infecções Oculares Virais/virologia , Previsões , Herpes Zoster Oftálmico/virologia , Herpesvirus Humano 3/genética , Síndrome de Necrose Retiniana Aguda/virologia , Simplexvirus/genética , Adolescente , Adulto , Idoso , Antivirais/administração & dosagem , Criança , Infecções Oculares Virais/complicações , Infecções Oculares Virais/tratamento farmacológico , Feminino , Herpes Zoster Oftálmico/complicações , Herpes Zoster Oftálmico/tratamento farmacológico , Herpesvirus Humano 3/isolamento & purificação , Humanos , Injeções Intravítreas , Terapia a Laser , Masculino , Pessoa de Meia-Idade , Descolamento Retiniano/etiologia , Descolamento Retiniano/prevenção & controle , Síndrome de Necrose Retiniana Aguda/complicações , Síndrome de Necrose Retiniana Aguda/tratamento farmacológico , Estudos Retrospectivos , Simplexvirus/isolamento & purificação , Acuidade Visual , Corpo Vítreo/virologia , Adulto Jovem
10.
J Ocul Pharmacol Ther ; 28(6): 640-2, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22731242

RESUMO

PURPOSE: To report on tamoxifen crystalline maculopathy in an 80-year-old patient and to review the ocular side effects of oral tamoxifen. METHODS: We report a case of an 80-year-old female patient who presented to our ophthalmic institute with painless gradual progressive diminution of vision in both eyes. She had a history of surgery for breast cancer after which she had been treated with oral tamoxifen citrate for 2 years before presentation. RESULTS: Our patient had profound visual impairment in both eyes. The anterior segments were found to be normal; in particular, the corneas were clear; the intraocular pressures in both eyes were 12 mm Hg. The perimacular region in both eyes showed deposits of multiple, fine crystalline material. Color vision was found to be impaired in both eyes and optical coherence tomography (OCT) confirmed the diagnosis of tamoxifen-induced maculopathy. CONCLUSION: Tamoxifen is a selective estrogen receptor modulator widely used in the treatment of hormone-responsive breast cancer. Ocular complications are rare with tamoxifen therapy and include cataract, vortex keratopathy, optic neuritis, and retinopathy. Crystalline maculopathy is one of the rare side effects of long-term tamoxifen use, which can be detected by noninvasive diagnostic tools such as OCT. Our patient is the oldest such patient reported in literature. Patients receiving tamoxifen therapy must be informed about the potential side-effects, and the need for serial ophthalmic examination to detect early signs of toxicity.


Assuntos
Antineoplásicos Hormonais/efeitos adversos , Macula Lutea/efeitos dos fármacos , Tamoxifeno/efeitos adversos , Idoso de 80 Anos ou mais , Antineoplásicos Hormonais/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Cristalização , Feminino , Humanos , Macula Lutea/patologia , Tamoxifeno/uso terapêutico , Tomografia de Coerência Óptica , Transtornos da Visão/induzido quimicamente , Transtornos da Visão/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA